RE:Not so good looking forwardLOL, they made a deal to sell two collection facilities, Ryplazim (their only revenue) and sold 30% of the voucher for $22M.
LMNL gets 70% of the voucher when sold. Should be about $70M coming from the voucher. Thats a total of $92M.
Had LMNL just sat on their hands and not made this dumb deal two weeks before FDA approval, they would have had $100M, kept the two collection facilities and kept Ryplazim and its revenue stream.
This is the deal StupsNewcamo thinks is good. Nothing left. Explains the down trending SP.